TY - JOUR
T1 - Electric Pulse-Mediated Gene Delivery to Various Animal Tissues
AU - Mir, Lluis M.
AU - Moller, Pernille H.
AU - André, Franck
AU - Gehl, Julie
N1 - Funding Information:
The authors acknowledge the financial support of the Danish Medical Research Council, CNRS, IGR, AFM (Association Française contre les Myopathies), and the EU Commission through the projects Cliniporator (QLK3‐1999‐00484) and Esope (QLK3‐2002‐02003) coordinated by L.M.M. The authors also acknowledge all their colleagues for fruitful discussions and collaborative work. F.A. is the recipient of an “aide aux etudes” from the AFM.
PY - 2005/12/1
Y1 - 2005/12/1
N2 - Electroporation designates the use of electric pulses to transiently permeabilize the cell membrane. It has been shown that DNA can be transferred to cells through a combined effect of electric pulses causing (1) permeabilization of the cell membrane and (2) an electrophoretic effect on DNA, leading the polyanionic molecule to move toward or across the destabilized membrane. This process is now referred to as DNA electrotransfer or electro gene transfer (EGT). Several studies have shown that EGT can be highly efficient, with low variability both in vitro and in vivo. Furthermore, the area transfected is restricted by the placement of the electrodes, and is thus highly controllable. This has led to an increasing use of the technology to transfer reporter or therapeutic genes to various tissues, as evidenced from the large amount of data accumulated on this new approach for non-viral gene therapy, termed electrogenetherapy (EGT as well). By transfecting cells with a long lifetime, such as muscle fibers, a very long-term expression of genes can be obtained. A great variety of tissues have been transfected successfully, from muscle as the most extensively used, to both soft (e.g., spleen) and hard tissue (e.g., cartilage). It has been shown that therapeutic levels of systemically circulating proteins can be obtained, opening possibilities for using EGT therapeutically. This chapter describes the various aspects of in vivo gene delivery by means of electric pulses, from important issues in methodology to updated results concerning the electrotransfer of reporter and therapeutic genes to different tissues.
AB - Electroporation designates the use of electric pulses to transiently permeabilize the cell membrane. It has been shown that DNA can be transferred to cells through a combined effect of electric pulses causing (1) permeabilization of the cell membrane and (2) an electrophoretic effect on DNA, leading the polyanionic molecule to move toward or across the destabilized membrane. This process is now referred to as DNA electrotransfer or electro gene transfer (EGT). Several studies have shown that EGT can be highly efficient, with low variability both in vitro and in vivo. Furthermore, the area transfected is restricted by the placement of the electrodes, and is thus highly controllable. This has led to an increasing use of the technology to transfer reporter or therapeutic genes to various tissues, as evidenced from the large amount of data accumulated on this new approach for non-viral gene therapy, termed electrogenetherapy (EGT as well). By transfecting cells with a long lifetime, such as muscle fibers, a very long-term expression of genes can be obtained. A great variety of tissues have been transfected successfully, from muscle as the most extensively used, to both soft (e.g., spleen) and hard tissue (e.g., cartilage). It has been shown that therapeutic levels of systemically circulating proteins can be obtained, opening possibilities for using EGT therapeutically. This chapter describes the various aspects of in vivo gene delivery by means of electric pulses, from important issues in methodology to updated results concerning the electrotransfer of reporter and therapeutic genes to different tissues.
UR - http://www.scopus.com/inward/record.url?scp=25144469504&partnerID=8YFLogxK
U2 - 10.1016/S0065-2660(05)54005-7
DO - 10.1016/S0065-2660(05)54005-7
M3 - Review article
C2 - 16096009
AN - SCOPUS:25144469504
SN - 0065-2660
VL - 54
SP - 83
EP - 114
JO - Advances in Genetics
JF - Advances in Genetics
ER -